These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 5647013)
21. [Affective disorders in the course of treatment with neuroleptics of children and adolescents with schizophrenia]. Semanovskaia EI Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(10):1529-34. PubMed ID: 4386295 [No Abstract] [Full Text] [Related]
22. [Phenothiazine retinopathy]. Henkes HE Ned Tijdschr Geneeskd; 1966 Apr; 110(17):789-90. PubMed ID: 5933712 [No Abstract] [Full Text] [Related]
23. Phenothiazine toxicity in paediatric practice with three case reports. Bajpai PC; Sethi VK; Pathak AK; Tripathi TK Indian Pediatr; 1969 Jul; 6(7):470-5. PubMed ID: 5345025 [No Abstract] [Full Text] [Related]
24. Prolonged pharmacotherapy and the eye. A symposium. The antimalarials and the tranquilizers. Rubin M Dis Nerv Syst; 1968 Mar; 29(3):Suppl:67-76. PubMed ID: 4233735 [No Abstract] [Full Text] [Related]
25. [Study of extrapyramidal manifestations induced by neuroleptics]. Bordeleau JM; Tétreault L Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291 [No Abstract] [Full Text] [Related]
26. Ocular complications of phenothiazines. Mathalone MB Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613 [No Abstract] [Full Text] [Related]
27. Drug-induced extrapyramidal symptoms: their incidence and treatment. Sheppard C; Merlis S Am J Psychiatry; 1967 Jan; 123(7):886-9. PubMed ID: 6016862 [No Abstract] [Full Text] [Related]
29. [On the development of leukopenia and agranulocytosis during therapy with preparaions of the phenothiazine series]. Rubinshteĭn AIu Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(10):1548-50. PubMed ID: 6000318 [No Abstract] [Full Text] [Related]
30. Agents which cause pigmentary retinopathy. Potts AM Dis Nerv Syst; 1968 Mar; 29(3):Suppl:16-8. PubMed ID: 5672558 [No Abstract] [Full Text] [Related]
32. [Pharmacological aspect of the treatment of hypotension induced by phenothiazine neuroleptics and monoamine oxidase inhibitors]. van den Driessche J; Allain P; Eben-Moussi E Sem Ther; 1966 Jan; 42(1):19-21. PubMed ID: 4383528 [No Abstract] [Full Text] [Related]
33. [Chloroquine retinopathy]. Jacobsen JR Nord Med; 1968 Jan; 79(3):75-8. PubMed ID: 5637266 [No Abstract] [Full Text] [Related]
34. [The cardiovascular effects of neuroleptics based on current knowledge]. Pieschl D Nervenarzt; 1973 Apr; 44(4):212-5. PubMed ID: 4573587 [No Abstract] [Full Text] [Related]
35. [The side effects of neuroleptic-therapy]. Fyrö B Lakartidningen; 1972 Mar; 69():89-94. PubMed ID: 4664130 [No Abstract] [Full Text] [Related]
36. [The neuroleptic syndrome. Attempted systematization of primary and secondary effects observed during neuroleptic treatments]. Lambert PA Encephale; 1971; 60(4):335-49. PubMed ID: 5004893 [No Abstract] [Full Text] [Related]
37. [Ophthalmologic study of patients receiving psychotropic drugs]. Gol'dovskaia IL Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196 [No Abstract] [Full Text] [Related]
38. Phenothiazines and eye complications. Valentine M; Jardine P Br Med J; 1966 Sep; 2(5513):586. PubMed ID: 5917372 [No Abstract] [Full Text] [Related]
39. Phenothiazines and diffuse melanosis. Greiner AC Agressologie; 1968; 9(2):219-24. PubMed ID: 5675489 [No Abstract] [Full Text] [Related]
40. [Comparative study of 2 drugs and a placebo in chronic schizophrenia]. Tetreault L Actual Pharmacol (Paris); 1969; 22():1-18. PubMed ID: 4927120 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]